2028 Healthcare Pharma 
World of DTC Marketing
JULY 28, 2022
Still, the pharma industry is fighting hard to keep it off the table. Late last year, the Senate Finance Committee released draft legislation enabling Medicare negotiation for up to 10 drugs in 2025, 15 in 2026 and 2027, and 20 in 2028 and beyond. Pharma is a very profitable industry. The secretary of the U.S.
PM360
JANUARY 24, 2025
For the past nine years, EVERSANA INTOUCH has done a look ahead: a forecast based on input from leaders on what trends may shape pharma marketing in the year ahead. Lets take a closer look at each of these trends: Applied AI: As excitement continues to grow and AI becomes more real, how is it being deployed by pharma marketers?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
DECEMBER 15, 2021
People are living longer, but there is a prediction of a global lack of healthcare workers to look after them, with a shortfall of 9.9 What’s so ironic is that pharma could develop an app to compliment some of their drugs. million doctors, nurses, and midwives expected by 2030. That’s a mistake also.
Contrarian Sales Techniques
FEBRUARY 10, 2023
Non-invasive healthcare products refer to medical devices or technologies that do not require puncturing the skin or entering the body in any way to diagnose, treat, or monitor a health condition. The market for non-invasive healthcare products is expected to grow significantly in the coming years.
Pharmaceutical Technology
NOVEMBER 8, 2022
Viatris has signed definitive agreements to acquire Oyster Point Pharma and Famy Life Sciences in a deal totalling nearly $700m-$750m in cash to establish an ophthalmology franchise. Oyster Point Pharma introduced Tyrvaya, a nasal spray approved by the Food and Drug Administration (FDA) to treat dry eye disease, in November last year.
pharmaphorum
JANUARY 5, 2023
A new operating model for pharma shifted priorities and forced companies to rethink their organisational strategies. Everything from transitioning to virtual meetings with healthcare providers, to navigating the logistics of supply chain disruptions, has permanently altered pharma operations – many would say for the better.
PM360
APRIL 7, 2023
No one has ever described the pharma market access landscape as simple or easy to understand, and the passage of the Inflation Reduction Act (IRA) is not likely to change that. Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders.
Expert insights. Personalized for you.
256 
Let's personalize your content